Experiments in human breast cancer cell lines have shown that Trop2 gene expression is downregulated within a couple of hours of either the inhibition of NF-κB's protein activity or by its reduction in translocation, which confirms a regulatory role of NFκB on the transcription of the Trop2 gene. This evidence concerns the gene TACSTD2 and breast carcinoma.